References
- Clin. Neuropharmacol. v.15 Tolerability of oral dextromethorphan in patients with a history of brain ischemia Albers,G.W.;Saenz,R.E.;Moses,Jr.J.A.
- Immunotoxicol. v.15 In vivo phencyclidine-induced inhibition of lymphocyte proliferation: Prevention by cell activation Di Francesco,P.;Gaziano,R.;Pica,F.;Palamara,A.T.;Innocenti,F.;Favalli,C.
- Int. J. Immunopharmac. v.11 Modulation of immune responses in mice by oral administration on nifulmic acid Florentin,I.;Maral,J.;De Sousa,M.;Berardet,M.;Hertz,F.;Cloarec,A.
- J. Immunol. v.134 Evidence for a β-adrenoreceptor- mediated regulation of human natural killer cells Hellstrand,K.;Hermodsson,S.;Strannegard
- Immunotoxicol. v.16 Immunological consequences of in vitro exposure to lysergic acid diethylamide (LSD) House,R.V.;Thomas,P.T.
- National Academy of Science/National Research Council v.1 Progress report on the assessment of the antagonist nalbuphine and GPA-2087 for abuse potential and studies of the effects of dextromethorphan in man Jasinski,P.R.;Martin,W.R.;Maski,P.A.
- The International Congress of Applied Psychology v.22 Drug abuse among Korean adolescents Jhoo, W.K.;Kim,H.C.
- Arch. Pharm. Res. v.18 Alterations in motor activity induced by high dose oral administration of dextromethorphan throughout two consecutive generations in mice Kim,H.C.;Jhoo,W.K.
- NeuroToxicol The effects of dextromethorphan on kainic acid-induced seizures in the rat Kim,H.C.;Pennypacker,K.R.;Bing,G.;Bronstein,D.;McMillian,M.K.;Hong,J.S.
- Physiol. Rev. v.75 Experimental basis for neural-immune interations Madden,K.S.;Felten,D.L.
- Science v.244 Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs Olney,J.W.;Labruyere,J.;Price,M.T.
- Trends Pharmacol. Sci. v.10 Dextromethorphan and neuromodulation: old drug coughs up new activities Tortella,F.C.;Pellicano,M.;Bowery,N.G.